Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
Polycythemia vera (PV) and essential thrombocythemia (ET) are two Philadelphia-negative myeloproliferative neoplasms (MPN) associated with an acquired mutation in the JAK2 tyrosine kinase gene. There is a rare incidence of progression to myelofibrosis and myeloid metaplasia in both disorders, which...
Saved in:
| Main Authors: | Fabrizio Vianello, Anna Battisti, Giuseppe Cella, Marina Marchetti, Anna Falanga |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2011.108 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulocytic Expression of CD11b/CD18 and Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Doroteya Todorieva-Todorova, et al.
Published: (2021-06-01) -
WCN24-2220 A DOUBLE HIT: CASE OF THROMBOTIC MICROANGIOPATHY CONCURRENT WITH MEMBRANOUS NEPHROPATHY IN A PATIENT WITH MYELOPROLIFERATIVE NEOPLASM
by: Yuliya Sharakova
Published: (2024-04-01) -
Pathogenesis and management of high molecular risk myeloproliferative neoplasms
by: Victoria Y. Ling, et al.
Published: (2024-12-01) -
LANDSCAPE OF SOMATIC MUTATIONS OF MYELOPROLIFERATIVE NEOPLASMS IN PAKISTANI PATIENTS
by: Mehreen Ali Khan
Published: (2025-07-01) -
Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Sylvie Hermouet, et al.
Published: (2015-01-01)